Advances in the molecular biology of malignant mesothelioma

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Malignant mesothelioma (MM) is an aggressive cancer with increasing incidence due to asbestos exposure.
• Understanding MM's molecular profile is crucial for diagnosis and treatment, especially given its distinction from lung cancer.
• While asbestos is a known cause, detailed molecular alterations in MM remain less understood compared to other cancers.

Purpose of the Study:

• To review the known molecular alterations in malignant mesothelioma.
• To differentiate MM's molecular profile from other cancers, particularly lung cancer.
• To identify areas for future research in MM pathogenesis and clinical application.

Main Methods:

• Review of existing literature on MM molecular biology.
• Analysis of genetic alterations, including gene deletions and mutations.
• Examination of epigenetic modifications like DNA methylation.

Main Results:

• Commonly observed are chromosome alterations, including homozygous deletions of P16 and P14 genes.
• Mutations in neurofibromatosis type 2 gene are frequent, while P53 and Ras mutations are rare.
• Distinct DNA methylation profiles in MM compared to lung cancer; overexpression of genes involved in proliferation, angiogenesis, and metastasis.

Conclusions:

• MM exhibits unique genetic and epigenetic alterations, necessitating further research for clinical application.
• Elucidating MM pathogenesis through extensive research is essential for improving patient prognosis.
• Simian virus 40 is implicated as a potential causative factor in some MM cases.